Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Brain Neoplasms 4Uterine Cervical Neoplasms 1Thyroid Neoplasms 1Stomach Neoplasms 1Prostatic Neoplasms 1Postoperative Complications 1Pancreatic Neoplasms 1Ovarian Neoplasms 1Ovarian Cysts 1Myofibroma 1Liver Neoplasms 1Encephalocele 1Cholecystitis 1Breast Neoplasms 1

Interventions

Radiosurgery 45Magnetic Resonance Spectroscopy 41Standard of Care 27Radiotherapy 27Exercise 27Brachytherapy 21Early Intervention, Educational 20Surveys and Questionnaires 18Multiparametric Magnetic Resonance Imaging 17Magnetic Resonance Imaging 16Androgen Antagonists 16Blood Specimen Collection 15Interviews as Topic 14Radiotherapy, Intensity-Modulated 13Methods 13Therapeutics 12Psychiatric Rehabilitation 12Educational Status 12Biopsy 12Specimen Handling 10Resistance Training 10Prostatectomy 9Diet Therapy 9Counseling 9gallium 68 PSMA-11 8Radiation 8Proton Therapy 8Practice Guidelines as Topic 8High-Intensity Interval Training 7Electroporation 7

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Prostatic Neoplasms × Remifentanil × Clear all
NCT01998685 2014-11-06

Prothrombotic Factors and Anaesthesia in Prostate Cancer

Regina Elena Cancer Institute

Phase NA Completed
200 enrolled
Genitourinary

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡